The Journal of clinical endocrinology and metabolism
Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial Extension.
Mishaela Rubin, Andrea Palermo, Tamara Vokes, Aliya A Khan, Peter Schwarz, Filomena Cetani, Uberto Pagotto, Elena Tsourdi, Tanja Sikjaer, Kathryn M Pfeiffer, Meryl Brod, Lori D McLeod, Carol Zhao, Wahidullah Noori, Aimee D Shu
Published: 202510.1210/clinem/dgaf653
Abstract
CONTEXT: Individuals with hypoparathyroidism experience a range of physical and cognitive symptoms and reduced quality of life (QoL) despite management with conventional therapy (active vitamin D and calcium). OBJECTIVE: This analysis investigated th…
Preview only. Read the full abstract at the source